These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37380638)

  • 41. Silencing of EPCAM suppresses hepatic fibrosis and hepatic stellate cell proliferation in mice with alcoholic hepatitis via the PI3K/Akt/mTOR signaling pathway.
    Zhang Z; Wen H; Weng J; Feng L; Liu H; Hu X; Zeng F
    Cell Cycle; 2019 Sep; 18(18):2239-2254. PubMed ID: 31378124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis.
    Kulkarni YM; Dutta S; Iyer AK; Venkatadri R; Kaushik V; Ramesh V; Wright CA; Semmes OJ; Yakisich JS; Azad N
    Proteomics; 2016 Jan; 16(1):33-46. PubMed ID: 26425798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The PI3K/AKT/mTOR pathway regulates autophagy to induce apoptosis of alveolar epithelial cells in chronic obstructive pulmonary disease caused by PM2.5 particulate matter.
    Zhang F; Ma H; Wang ZL; Li WH; Liu H; Zhao YX
    J Int Med Res; 2020 Jul; 48(7):300060520927919. PubMed ID: 32715876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcitriol inhibits bleomycin-induced early pulmonary inflammatory response and epithelial-mesenchymal transition in mice.
    Tan ZX; Chen YH; Xu S; Qin HY; Zhang C; Zhao H; Xu DX
    Toxicol Lett; 2016 Jan; 240(1):161-71. PubMed ID: 26520185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vasoactive intestinal peptide attenuates bleomycin-induced murine pulmonary fibrosis by inhibiting epithelial-mesenchymal transition: Restoring autophagy in alveolar epithelial cells.
    Duan JX; Guan XX; Yang HH; Mei WX; Chen P; Tao JH; Li Q; Zhou Y
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108211. PubMed ID: 34634687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
    Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis.
    Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H
    BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
    Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
    Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Baicalin alleviates bleomycin-induced early pulmonary fibrosis in mice via the mitoKATP signaling pathway.
    Han M; Wang S; Zhou X; Zhang P; Han Z; Chen Y; Cai H; Wu L; Huang X; Wang L; Chen Y
    Toxicology; 2023 Oct; 497-498():153638. PubMed ID: 37783230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppressing NLRP3 activation and PI3K/AKT/mTOR signaling ameliorates amiodarone-induced pulmonary fibrosis in rats: a possible protective role of nobiletin.
    El Tabaa MM; El Tabaa MM; Elgharabawy RM; Abdelhamid WG
    Inflammopharmacology; 2023 Jun; 31(3):1373-1386. PubMed ID: 36947298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway.
    Li XH; Xiao T; Yang JH; Qin Y; Gao JJ; Liu HJ; Zhou HG
    Respir Res; 2018 Jun; 19(1):111. PubMed ID: 29871641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.
    Lawrence J; Nho R
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autophagy modulation by irbesartan mitigates the pulmonary fibrotic alterations in bleomycin challenged rats: Comparative study with rapamycin.
    Alsayed HA; Mohammad HMF; Khalil CM; El-Kherbetawy MK; Elaidy SM
    Life Sci; 2022 Aug; 303():120662. PubMed ID: 35636582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigallocatechin Gallate Relieved PM2.5-Induced Lung Fibrosis by Inhibiting Oxidative Damage and Epithelial-Mesenchymal Transition through AKT/mTOR Pathway.
    Zhongyin Z; Wei W; Juan X; Guohua F
    Oxid Med Cell Longev; 2022; 2022():7291774. PubMed ID: 35707275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of ER stress, PI3K/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis.
    Hsu HS; Liu CC; Lin JH; Hsu TW; Hsu JW; Su K; Hung SC
    Sci Rep; 2017 Oct; 7(1):14272. PubMed ID: 29079731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis.
    Jiang Y; Hu F; Li Q; Shen C; Yang J; Li M
    Int Immunopharmacol; 2019 Dec; 77():105968. PubMed ID: 31704290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A critical role for the mTORC2 pathway in lung fibrosis.
    Chang W; Wei K; Ho L; Berry GJ; Jacobs SS; Chang CH; Rosen GD
    PLoS One; 2014; 9(8):e106155. PubMed ID: 25162417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dragon's Blood exerts cardio-protection against myocardial injury through PI3K-AKT-mTOR signaling pathway in acute myocardial infarction mice model.
    Li C; Zhang Y; Wang Q; Meng H; Zhang Q; Wu Y; Xiao W; Wang Y; Tu P
    J Ethnopharmacol; 2018 Dec; 227():279-289. PubMed ID: 30195568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Andrographolide alleviates bleomycin-induced NLRP3 inflammasome activation and epithelial-mesenchymal transition in lung epithelial cells by suppressing AKT/mTOR signaling pathway.
    Li J; Yang X; Yang P; Xu K; Peng X; Cai W; Zhao S; Hu L; Li Z; Cui F; Wang W; Peng G; Xu X; He J; Liu J
    Ann Transl Med; 2021 May; 9(9):764. PubMed ID: 34268377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.